Meta-analysis of the relationship between 14bp insertion/deletion polymorphism of HLA-G gene and susceptibility to systemic lupus erythematosus

Human Immunology

Volumn 75, Issue 12, 2014, Pages 1171-1176

  Zhang, Xiaolian ^a   Li, Shan ^a   Zhang, Ying ^b   Lu, Yu ^a   Wang, Jian ^a   Xu, Juanjuan ^a   Li, Xi ^a   Qin, Xue ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b RUIKANG HOSPITAL AFFILIATED TO GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

HLA G; Meta analysis; Polymorphism; SLE; Susceptibility

Indexed keywords

HLA G ANTIGEN;

ASIAN; CASE CONTROL STUDY; CAUCASIAN; ETHNICITY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INDEL MUTATION; META ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS;

GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-G ANTIGENS; HUMANS; INDEL MUTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, GENETIC;

EID: 84927518871     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.10.008     Document Type: Review

References (41)

1. Tsokos G.C. Systemic lupus erythematosus. N Engl J Med 2011, 365:2110.
2. Harley J.B., Kelly J.A., Kaufman K.M. Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 2006, 28:119.
3. Alarcon-Riquelme M.E. Family studies in systemic lupus erythematosus. Rheumatology (Oxford) 2002, 41:364.
4. Deapen D., Escalante A., Weinrib L., Horwitz D., Bachman B., Roy-Burman P., et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992, 35:311.
5. Forabosco P., Gorman J.D., Cleveland C., Kelly J.A., Fisher S.A., Ortmann W.A., et al. Meta-analysis of genome-wide linkage studies of systemic lupus erythematosus. Genes Immun 2006, 7:609.
6. Favier B., LeMaoult J., Rouas-Freiss N., Moreau P., Menier C., Carosella E.D. Research on HLA-G: an update. Tissue Antigens 2007, 69:207.
7. Consiglio C.R., Veit T.D., Monticielo O.A., Mucenic T., Xavier R.M., Brenol J.C., et al. Association of the HLA-G gene +3142C>G polymorphism with systemic lupus erythematosus. Tissue Antigens 2011, 77:540.
8. He X., Dong D.D., Yie S.M., Yang H., Cao M., Ye S.R., et al. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro. Ann Surg Oncol 2010, 17:1459.
9. Apps R., Gardner L., Moffett A. A critical look at HLA-G. Trends Immunol 2008, 29:313.
10. Jassem R.M., Shani W.S., Loisel D.A., Sharief M., Billstrand C., Ober C. HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq. Hum Immunol 2012, 73:811.
11. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248:220.
12. Eskandari-Nasab E., Hashemi M., Hasani S.S., Omrani M., Taheri M., Mashhadi M.A. Association between HLA-G 3'UTR 14-bp ins/del polymorphism and susceptibility to breast cancer. Cancer Biomark 2013, 13:253.
13. Teixeira A.C., Mendes-Junior C.T., Souza F.F., Marano L.A., Deghaide N.H., Ferreira S.C., et al. The 14bp-deletion allele in the HLA-G gene confers susceptibility to the development of hepatocellular carcinoma in the Brazilian population. Tissue Antigens 2013, 81:408.
14. Capittini C., Bergamaschi P., Sachetto S., Truglio M., Viola M., Marchesi A., et al. The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors. Blood Transfus 2014, 12(Suppl. 1):s361.
15. Chen X.Q., Wang H.Y., Gao Y., Yu L.L., Chen D., Zheng X.Q. Association of HLA-G 14bp gene polymorphisms and plasma sHLA-G level with susceptibility to EV71 infection in children. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2012, 26:429.
16. Carosella E.D., Moreau P., Aractingi S., Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol 2001, 22:553.
17. Verbruggen L.A., Rebmann V., Demanet C., De Cock S., Grosse-Wilde H. Soluble HLA-G in rheumatoid arthritis. Hum Immunol 2006, 67:561.
18. Rizzo R., Hviid T.V., Govoni M., Padovan M., Rubini M., Melchiorri L., et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 2008, 71:520.
19. Rosado S., Perez-Chacon G., Mellor-Pita S., Sanchez-Vegazo I., Bellas-Menendez C., Citores M.J., et al. Expression of human leukocyte antigen-G in systemic lupus erythematosus. Hum Immunol 2008, 69:9.
20. Dahl M., Hviid T.V. Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss. Hum Reprod Update 2012, 18:92.
21. Chen X.Y., Yan W.H., Lin A., Xu H.H., Zhang J.G., Wang X.X. The 14bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008, 72:335.
22. Zou Y.F., Wang F., Feng X.L., Tao J.H., Zhu J.M., Pan F.M., et al. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Tissue Antigens 2011, 77:9.
23. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539.
24. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557.
25. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177.
26. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719.
27. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629.
28. Wu F.X., Wu L.J., Luo X.Y., Yang M.H., Liu N.T., Song X.Y., et al. Association of the HLA-G 14bp ins/del polymorphism with systemic lupus erythematosus. Chin. J. Allergy Clin. Immunol. 2009, 167.
29. Wu F.X., Wu L.J., Luo X.Y., Yang M.H., Liu N.T., Xie C.M., et al. A study about HLA-G 14bp ins/del polymorphism and plasma sHLA-G expression levels in systemic lupus erythematosus. Chin. J. Clin. (Electronic Edition) 2010, 144.
30. Pedroza L.S., Sauma M.F., Vasconcelos J.M., Takeshita L.Y., Ribeiro-Rodrigues E.M., Sastre D., et al. Systemic lupus erythematosus: association with KIR and SLC11A1 polymorphisms, ethnic predisposition and influence in clinical manifestations at onset revealed by ancestry genetic markers in an urban Brazilian population. Lupus 2011, 20:265.
31. Lucena-Silva N., de Souza V.S., Gomes R.G., Fantinatti A., Muniz Y.C., de Albuquerque R.S., et al. HLA-G 3' untranslated region polymorphisms are associated with systemic lupus erythematosus in 2 Brazilian populations. J Rheumatol 2013, 40:1104.
32. Veit T.D., Cordero E.A., Mucenic T., Monticielo O.A., Brenol J.C., Xavier R.M., et al. Association of the HLA-G 14bp polymorphism with systemic lupus erythematosus. Lupus 2009, 18:424.
33. Wu F.X., Wu L.J., Luo X.Y., Tang Z., Yang M.H., Xie C.M., et al. Lack of association between HLA-G 14-bp polymorphism and systemic lupus erythematosus in a Han Chinese population. Lupus 2009, 18:1259.
34. Mu L.J., Yuan M., Tang Y.J., Huang X.F., Qian X.X., Qu B., et al. Association of the HLA-G 14bp polymorphism with systemic lupus erythematosus in a Chinese population. Curr. Immunol. 2009, 270.
35. Chen TT, Yu L, Huang K, Sun H, Lin KQ, Huang XQ, et al. Association between HLA-G 14bp polymorphism and systemic lupus erythematosus in a Han Chinese population. In: The genetics society of China ninth national member congress and symposium, Harbin, Heilongjiang Province, China, 2013, p. 1.
36. Shi L., Wei Y., Xun W., Han D. Meta-analysis of the correlation between PTPN22 gene polymorphisms and susceptibility to systemic lupus erythematosus. Asia Pac J Public Health 2013, 25:22S.
37. Sullivan K.E. Genetics of systemic lupus erythematosus. Clinical implications. Rheum Dis Clin North Am 2000, 26:229.
38. Baricordi O.R., Stignani M., Melchiorri L., Rizzo R. HLA-G and inflammatory diseases. Inflamm Allergy Drug Targets 2008, 7:67.
39. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008, 111:4862.
40. Rousseau P., Le Discorde M., Mouillot G., Marcou C., Carosella E.D., Moreau P. The 14bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003, 64:1005.
41. Hviid T.V., Rizzo R., Christiansen O.B., Melchiorri L., Lindhard A., Baricordi O.R. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004, 56:135.